急诊科疑似急性感染与脓毒症患者转录组严重度分类器的前瞻性验证
本研究为前瞻性观察性便利队列,纳入急诊科疑似急性感染患者312例,其中22例(7.1%)院内死亡,58例(18.6%)在就诊后72小时内发生多器官衰竭。采用全血RNA管分析29个宿主mRNA分类器IMX-SEV-2生成严重度风险评分,并与院内死亡和72小时多器官衰竭结局比较。预测院内死亡时,IMX-SEV-2的AUROC为0.84(95%CI 0.76-0.93),显著高于乳酸0.76(0.64-0.87)、qSOFA 0.68(0.57-0.79)和NEWS2 0.75(0.65-0.85),P值分别为0.015、0.001和0.013。预测72小时多器官衰竭时,IMX-SEV-2的AUROC为0.76(0.68-0.83),与乳酸0.73(0.65-0.81)、qSOFA 0.77(0.70-0.83)和NEWS2 0.81(0.75-0.86)无显著差异。
要点
- 在312例急诊疑似急性感染患者中,IMX-SEV-2预测院内死亡的AUROC为0.84(95%CI 0.76-0.93),显著高于乳酸0.76(0.64-0.87)、qSOFA 0.68(0.57-0.79)和NEWS2 0.75(0.65-0.85),P值分别为0.015、0.001和0.013。
- IMX-SEV-2预测72小时多器官衰竭的AUROC为0.76(0.68-0.83),与乳酸0.73(0.65-0.81)、qSOFA 0.77(0.70-0.83)和NEWS2 0.81(0.75-0.86)无显著差异。
- 队列中院内死亡22例(7.1%),72小时内多器官衰竭58例(18.6%)。
- 作者认为,识别高死亡风险或多器官衰竭风险的患者可能改善患者结局、资源利用并指导治疗决策。
适用人群与场景
- 急诊科疑似急性感染的患者,前瞻性观察性便利队列,共312例符合条件。
研究设计与关键结果
- 研究类型:前瞻性观察性便利队列;样本量312例急诊疑似急性感染患者;干预/方法:全血RNA管分析独立训练和验证的复合靶基因(IMX-SEV-2)生成严重度风险评分;对照:乳酸、qSOFA、NEWS2;主要终点:院内死亡和72小时多器官衰竭。
- 院内死亡22例(7.1%),72小时内多器官衰竭58例(18.6%)。
- 预测院内死亡:IMX-SEV-2的AUROC为0.84(95%CI 0.76-0.93),显著高于乳酸0.76(0.64-0.87)(P=0.015)、qSOFA 0.68(0.57-0.79)(P=0.001)和NEWS2 0.75(0.65-0.85)(P=0.013)。
- 预测72小时多器官衰竭:IMX-SEV-2的AUROC为0.76(0.68-0.83),与乳酸0.73(0.65-0.81)、qSOFA 0.77(0.70-0.83)和NEWS2 0.81(0.75-0.86)无显著差异。
证据类型、等级与局限
- 证据类型:前瞻性观察性验证研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,识别高死亡风险或多器官衰竭风险的患者可能改善患者结局、资源利用并指导治疗决策。
- 在急诊疑似急性感染患者中,IMX-SEV-2对院内死亡的预测优于乳酸、qSOFA和NEWS2,但对72小时多器官衰竭的预测未优于这些现有评分或生物标志物。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND AND IMPORTANCE: mRNA-based host response signatures have been reported to improve sepsis diagnostics. Meanwhile, prognostic markers for the rapid and accurate prediction of severity in patients with suspected acute infections and sepsis remain an unmet need. IMX-SEV-2 is a 29-host-mRNA classifier designed to predict disease severity in patients with acute infection or sepsis.
OBJECTIVE: Validation of the host-mRNA infection severity classifier IMX-SEV-2.
DESIGN, SETTINGS AND PARTICIPANTS: Prospective, observational, convenience cohort of emergency department (ED) patients with suspected acute infections.
OUTCOME MEASURES AND ANALYSIS: Whole blood RNA tubes were analyzed using independently trained and validated composite target genes (IMX-SEV-2). IMX-SEV-2-generated risk scores for severity were compared to the patient outcomes in-hospital mortality and 72-h multiorgan failure.
MAIN RESULTS: Of the 312 eligible patients, 22 (7.1%) died in hospital and 58 (18.6%) experienced multiorgan failure within 72 h of presentation. For predicting in-hospital mortality, IMX-SEV-2 had a significantly higher area under the receiver operating characteristic (AUROC) of 0.84 [95% confidence intervals (CI), 0.76-0.93] compared to 0.76 (0.64-0.87) for lactate, 0.68 (0.57-0.79) for quick Sequential Organ Failure Assessment (qSOFA) and 0.75 (0.65-0.85) for National Early Warning Score 2 (NEWS2), ( P = 0.015, 0.001 and 0.013, respectively). For identifying and predicting 72-h multiorgan failure, the AUROC of IMX-SEV-2 was 0.76 (0.68-0.83), not significantly different from lactate (0.73, 0.65-0.81), qSOFA (0.77, 0.70-0.83) or NEWS2 (0.81, 0.75-0.86).
CONCLUSION: The IMX-SEV-2 classifier showed a superior prediction of in-hospital mortality compared to biomarkers and clinical scores among ED patients with suspected infections. No improvement for predicting multiorgan failure was found compared to established scores or biomarkers. Identifying patients with a high risk of mortality or multiorgan failure may improve patient outcomes, resource utilization and guide therapy decision-making.
参考来源
- Galtung N, Diehl-Wiesenecker E, Lehmann D, et al. Prospective validation of a transcriptomic severity classifier among patients with suspected acute infection and sepsis in the emergency department. Eur J Emerg Med. 2022. PMID: 35467566. doi:10.1097/MEJ.0000000000000931
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。